Present to future: what the reasons for declining first-trimester combined testing tell us about accepting or declining cell-free DNA testing

被引：14
|
作者：
Crombag, Neeltje M. T. H. [1 ]
van Schendel, Rachel V. [2 ,3 ]
Schielen, Peter C. J. I. [4 ]
Bensing, Jozien M. [5 ,6 ]
Henneman, Lidewij [2 ,3 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Sect Community Genet, Dept Clin Genet, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands
[5] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands
[6] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands
来源：
PRENATAL DIAGNOSIS | 2016年 / 36卷 / 06期
关键词：
PREGNANT-WOMEN; TRISOMY-21; ATTITUDES;
D O I：
10.1002/pd.4824
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：587 / 590
页数：4
相关论文
共 30 条
  • [1] Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?
    Dap, Matthieu
    Caffin, Lucie
    Perdriolle-Galet, Estelle
    Bonnet, Celine
    Morel, Olivier
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (04)
  • [2] Cell-free DNA testing in the maternal blood in high-risk pregnancies after first-trimester combined screening
    Persico, Nicola
    Boito, Simona
    Ischia, Benedetta
    Cordisco, Adalgisa
    De Robertis, Valentina
    Fabietti, Isabella
    Periti, Enrico
    Volpe, Paolo
    Fedele, Luigi
    Rembouskos, Georgios
    PRENATAL DIAGNOSIS, 2016, 36 (03) : 232 - 236
  • [3] First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing
    Nicolaides, K. H.
    Wright, D.
    Poon, L. C.
    Syngelaki, A.
    Gil, M. M.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (01) : 41 - 50
  • [4] Women who choose cell-free DNA testing should not be denied first-trimester anatomy scan
    Alfirevic, Z.
    Bilardo, C. M.
    Salomon, L. J.
    Tabor, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (08) : 1159 - 1161
  • [5] Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy
    Sarno, L.
    Revello, R.
    Hanson, E.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (06) : 705 - 711
  • [6] Association Between Fetal Fraction on Cell-Free DNA Testing and First-Trimester Markers for Pre-eclampsia
    Rolnik, D. L.
    Costa, F. Da Silva
    Lee, T. J.
    Schmid, M.
    McLennan, A. C.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (05) : 265 - 266
  • [7] Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia
    Rolnik, D. L.
    Costa, F. da Silva
    Lee, T. J.
    Schmid, M.
    McLennan, A. C.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 52 (06) : 722 - 727
  • [8] First trimester screening: An obsolete concept in the era of cell-free DNA testing?
    Wagner P.
    Hoopmann M.
    Kagan K.O.
    Der Gynäkologe, 2018, 51 (1): : 12 - 18
  • [9] First-Trimester Contingent Screening for Trisomies 21, 18 and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing
    Nicolaides, K. H.
    Syngelaki, A.
    Poon, L. C.
    Gil, M. M.
    Wright, D.
    FETAL DIAGNOSIS AND THERAPY, 2014, 35 (03) : 185 - 192
  • [10] Analysis of first-trimester combined test results in preparation for a cell-free fetal DNA era
    Kose, Semir
    Cimrin, Dilek
    Yildirim, Nuri
    Aksel, Ozge
    Keskinoglu, Pembe
    Bora, Elcin
    Cankaya, Tufan
    Altunyurt, Sabahattin
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 135 (02) : 187 - 191
123